$298 Million is the total value of TIGER MANAGEMENT L.L.C.'s 43 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $30,986,000 | -7.2% | 1,115,411 | 0.0% | 10.41% | +9.8% | |
BABA | ALIBABA GROUP HLDG LTDsponsored ads | $12,447,000 | -8.3% | 64,000 | 0.0% | 4.18% | +8.4% | |
GOOG | ALPHABET INCcap stk cl c | $11,629,000 | -13.0% | 10,001 | 0.0% | 3.91% | +2.8% | |
RYAAY | RYANAIR HOLDINGS PLCsponsored ads | $5,165,000 | -39.4% | 97,296 | 0.0% | 1.74% | -28.4% | |
SVMK | SVMK INC | $3,275,000 | -24.4% | 242,413 | 0.0% | 1.10% | -10.6% | |
GOOGL | ALPHABET INCcap stk cl a | $3,190,000 | -13.2% | 2,745 | 0.0% | 1.07% | +2.6% | |
SPOT | SPOTIFY TECHNOLOGY S A | $1,470,000 | -18.8% | 12,101 | 0.0% | 0.49% | -3.9% | |
IQV | IQVIA HLDGS INC | $712,000 | -30.2% | 6,600 | 0.0% | 0.24% | -17.6% | |
SHY | ISHARES TR1 3 yr treas bd | $555,000 | +2.4% | 6,408 | 0.0% | 0.19% | +20.8% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $397,000 | -25.0% | 137,728 | 0.0% | 0.13% | -11.3% | |
SEE | SEALED AIR CORP NEW | $296,000 | -37.8% | 11,963 | 0.0% | 0.10% | -26.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
META PLATFORMS INC | 34 | Q1 2022 | 10.8% |
MICROSOFT CORP | 28 | Q1 2023 | 12.7% |
DELTA AIR LINES INC DEL | 28 | Q1 2023 | 8.5% |
SEALED AIR CORP NEW | 28 | Q1 2020 | 0.2% |
ALPHABET INC | 27 | Q3 2022 | 15.1% |
CONTROLADORA VUELA COMP DE A | 27 | Q1 2022 | 6.7% |
RYANAIR HOLDINGS PLC | 26 | Q1 2022 | 2.5% |
ISHARES TR | 25 | Q1 2020 | 0.5% |
CARNIVAL CORP | 24 | Q2 2019 | 0.1% |
GILEAD SCIENCES INV | 22 | Q3 2018 | 13.4% |
View TIGER MANAGEMENT L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
OOMA INC | February 14, 2019 | 800,423 | 4.0% |
T2 Biosystems, Inc. | February 14, 2019 | 820,499 | 1.9% |
Enzymotec Ltd. | July 01, 2016 | 577,407 | 2.5% |
LCA VISION INCSold out | December 20, 2013 | 0 | 0.0% |
GEVITY HR INC | March 17, 2006 | 1,382,439 | 5.2% |
GEVITY HR INC | January 21, 2005 | 1,476,200 | 5.4% |
View TIGER MANAGEMENT L.L.C.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View TIGER MANAGEMENT L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.